A Small Molecule Inverse Agonist for the Human Thyroid-Stimulating Hormone ReceptorNEUMANN, Susanne; WENWEI HUANG; ELISEEVA, Elena et al.Endocrinology (Philadelphia). 2010, Vol 151, Num 7, pp 3454-3459, issn 0013-7227, 6 p.Article

Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activityCHEN, Chun-Rong; MCLACHLAN, Sandra M; RAPOPORT, Basil et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 5, pp 2375-2382, issn 0013-7227, 8 p.Article

Anxiogenic properties of an inverse agonist selective for α3 subunit-containing GABA_A receptorsATACK, John R; HUTSON, Peter H; DAWSON, Gerard R et al.British journal of pharmacology. 2005, Vol 144, Num 3, pp 357-366, issn 0007-1188, 10 p.Article

Inverse Agonist of Nuclear Receptor ERRγ Mediates Antidiabetic Effect Through Inhibition of Hepatic GluconeogenesisKIM, Don-Kyu; GANG, Gil-Tae; CHEOL SOO CHOI et al.Diabetes (New York, NY). 2013, Vol 62, Num 9, pp 3093-3102, issn 0012-1797, 10 p.Article

Ac His¹ [D-Phe², K¹⁵, R¹⁶, L²⁷] VIP (3-7)/GRF (8-27) - a VPAC₁ receptor antagonist: is an inverse agonist on two constitutively active truncated VPAC₁ receptorsVERTONGEN, Pascale; LANGLET, Christelle; LANGER, Ingrid et al.Peptides (New York, NY. 1980). 2004, Vol 25, Num 11, pp 1943-1949, issn 0196-9781, 7 p.Article

Future trends : A new generation of retinoids. DiscussionCHANDRARATNA, R. A. S.Journal of the American Academy of Dermatology. 1998, Vol 39, Num 4, pp S149-S152, issn 0190-9622, 2Conference Paper

Negative antagonists promote as inactive conformation of the β₂-adrenergic receptorSAMAMA, P; GANG PEI; COSTA, T et al.Molecular pharmacology. 1994, Vol 45, Num 3, pp 390-394, issn 0026-895XArticle

SB265610 is an allosteric, inverse agonist at the human CXCR2 receptorBRADLEY, M. E; BOND, M. E; MANINI, J et al.British journal of pharmacology. 2009, Vol 158, Num 1, pp 328-338, issn 0007-1188, 11 p.Article

Identification of Key Amino Acid Residues in a Thyrotropin Receptor Monoclonal Antibody Epitope Provides Insight into Its Inverse Agonist and Antagonist PropertiesCHEN, Chun-Rong; MCLACHLAN, Sandra M; RAPOPORT, Basil et al.Endocrinology (Philadelphia). 2008, Vol 149, Num 7, pp 3427-3434, issn 0013-7227, 8 p.Article

Inverse agonist properties of atypical antipsychotic drugsAKAM, Elizabeth; STRANGE, Philip G.Biochemical pharmacology. 2004, Vol 67, Num 11, pp 2039-2045, issn 0006-2952, 7 p.Article

Analyse des effets de deux ligands des récepteurs centraux des benzodiazépines sur l'apprentissage chez la souris = Analysis of the effects of two central benzodiazepine receptor ligands on learning in mouseRaffalli-Sebille, Marie-Joseph; Chapouthier, G.1994, 146 p.Thesis

4,5-Dihydropyridazin-3-one derivatives as histamine H₃ receptor inverse agonistsHUDKINS, Robert L; AIMONE, Lisa D; ZULLI, Allison L et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 194-198, issn 0960-894X, 5 p.Article

Acute Alertness-Promoting Effects of a Novel Histamine Subtype-3 Receptor Inverse Agonist in Healthy Sleep-Deprived Male VolunteersIANNONE, R; PALCZA, J; RENGER, J. J et al.Clinical pharmacology and therapeutics. 2010, Vol 88, Num 6, pp 831-839, issn 0009-9236, 9 p.Article

Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT₇ receptorsMAHE, Cécile; LOETSCHER, Erika; FEUERBACH, Dominik et al.European journal of pharmacology. 2004, Vol 495, Num 2-3, pp 97-102, issn 0014-2999, 6 p.Article

Effects of the benzodiazepine inverse agonist RO19-4603 alone and in combination with the benzodiazepine receptor antagonists flumazenil, ZK 93426 and CGS 8216, on ethanol intake in alcohol-preferring (P) ratsJUNE, H. L; GREENE, T. L; LUMENG, L et al.Brain research. 1996, Vol 734, Num 1-2, pp 19-34, issn 0006-8993Article

Neurosteroid pregnenolone induces sleep-EEG changes in man compatible with inverse agonistic GABA_A-receptor modulationSTEIGER, A; TRACHSEL, L; GULDNER, J et al.Brain research. 1993, Vol 615, Num 2, pp 267-274, issn 0006-8993Article

Stimulant effect of the β-carboline FG 7142 in the open-field testBRUHWYLER, J; CHLEIDE, E; HOUBEAU, G et al.European journal of pharmacology. 1991, Vol 200, Num 1, pp 183-185, issn 0014-2999, 3 p.Article

Inverse agonism or neutral antagonism at G-protein coupled receptors : A médicinal chemistry challenge worth pursuing?GREASLEY, Peter J; CLAPHAM, John C.European journal of pharmacology. 2006, Vol 553, Num 1-3, pp 1-9, issn 0014-2999, 9 p.Article

Role of GABA_A α5-containing receptors in ethanol reward : The effects of targeted gene deletion, and a selective inverse agonistSTEPHENS, David N; PISTOVCAKOVA, Jana; WORTHING, Lynn et al.European journal of pharmacology. 2005, Vol 526, Num 1-3, pp 240-250, issn 0014-2999, 11 p.Conference Paper

Effects of benzodiazepine receptor inverse agonists on locomotor activity and exploration in miceJACKSON, H. C; NUTT, D. J.European journal of pharmacology. 1992, Vol 221, Num 2-3, pp 199-203, issn 0014-2999Article

Effects of the benzodiazepine receptor inverse agonist, DMCM, on the behaviour of mice : an ethopharmacological studyCUTLER, M. G; AITKEN, C. C.Neuropharmacology. 1991, Vol 30, Num 12A, pp 1255-1261, issn 0028-3908Article

Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogueLABARRE, Maryse; BUTTERWORTH, Joanne; ST-ONGE, Stephane et al.European journal of pharmacology. 2000, Vol 406, Num 1, pp R1-R3, issn 0014-2999Article

Mechanisms of inverse agonism of antipsychotic drugs at the D₂ dopamine receptor : use of a mutant D₂ dopamine receptor that adopts the activated conformationWILSON, Janet; HONG LIN; DINGYI FU et al.Journal of neurochemistry. 2001, Vol 77, Num 2, pp 493-504, issn 0022-3042Article

Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEPSUTER, Todd M; CHESTERFIELD, Amy K; CHUN BAO et al.European journal of pharmacology. 2010, Vol 649, Num 1-3, pp 44-50, issn 0014-2999, 7 p.Article

Serotonin 5-HT_2C receptor homodimerization is not regulated by agonist or inverse agonist treatmentHERRICK-DAVIS, Katharine; GRINDE, Ellinor; WEAVER, Barbara A et al.European journal of pharmacology. 2007, Vol 568, Num 1-3, pp 45-53, issn 0014-2999, 9 p.Article